Samuele Cortese, MD: COVID-19 Offers Opportunity for ADHD Patients

February 3, 2021
Kenny Walter

Kenny Walter is an editor with HCPLive. Prior to joining MJH Life Sciences in 2019, he worked as a digital reporter covering nanotechnology, life sciences, material science and more with R&D Magazine. He graduated with a degree in journalism from Temple University in 2008 and began his career as a local reporter for a chain of weekly newspapers based on the Jersey shore. When not working, he enjoys going to the beach and enjoying the shore in the summer and watching North Carolina Tar Heel basketball in the winter.

Dr. Cortese explains how more data could improve ADHD care.

The ongoing coronavirus disease 2019 (COVID-19) pandemic might change exactly how attention deficit/hyperactivity disorder (ADHD) is treated.

With many students forced to go to school over the computer and workers across the globe forced to work from home there undoubtedly will be some challenges and struggles for this patient population.

In an interview with HCPLive®, Samuele Cortese, MD, PhD, Professor of Child and Adolescent Psychiatry, University of Southampton, explained what he thinks will be some issues moving forward for ADHD patients and how doctors can handle some of the challenges linked to the pandemic.

Cortese said the pandemic has strengthened the idea there is a patient’s quality of life could substantially improve if ADHD is treated correctly. He said the cognitive symptoms must be first and foremost in crafting an individual treatment plan and by doing so doctors can improve the other aspects of the patient’s life.

One bright spot of the pandemic, Cortese said, is that there will be more data available on what ADHD patients are facing and struggling with.